Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Air Products & Chemicals, Inc.APD · Entity 2983 | Director | September 30, 2026 | October 01, 2026 |
| American Airlines Group Inc.AAL · Entity 3599 | Director | June 10, 2026 | June 12, 2026 |
| DOW INC.DOW · Entity 3233 | President and CFO | March 13, 2023 | March 15, 2023 |
| Kyndryl Holdings, Inc.KD · Entity 2161 | Director | July 30, 2026 | August 03, 2026 |
| Phillips 66PSX · Entity 2915 | Director | March 16, 2026 | March 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Air Products & Chemicals, Inc.
Report date September 30, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 981.6371 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 6.323 · Balance 981.6371 F1: Phantom deferred stock units (Units) acquired under the Air Products Stock Account of the issuer's Deferred Compensation Program for Directors, under the Company's Long-Term Incentive Plan. F2: Not applicable to this security F3: These Units are payable in the form of shares of common stock equal in number to the Units, at the time elected by the reporting person, which is generally after service on the Company's Board of Directors ends. Units may be paid in a lump sum or up to ten installments as elected by the reporting person in advance. |
Filing footnotes · ownership attribution and instrument terms
F1: Phantom deferred stock units (Units) acquired under the Air Products Stock Account of the issuer's Deferred Compensation Program for Directors, under the Company's Long-Term Incentive Plan.
F2: Not applicable to this security
F3: These Units are payable in the form of shares of common stock equal in number to the Units, at the time elected by the reporting person, which is generally after service on the Company's Board of Directors ends. Units may be paid in a lump sum or up to ten installments as elected by the reporting person in advance.
American Airlines Group Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,578 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 11,177 · Balance 36,578 F1: Restricted stock units will vest fully upon the earlier of June 10, 2027, or the next annual meeting of stockholders following the grant date, subject to the continued service of the reporting person through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units will vest fully upon the earlier of June 10, 2027, or the next annual meeting of stockholders following the grant date, subject to the continued service of the reporting person through the vesting date.
DOW INC.
Report date March 13, 2023 · Filed March 15, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 149,891 |
Reported balance
After 2023-03-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-03-13 · Disposition to issuer · Disposed 30,170 · Balance 149,891 F1: Shares used to satisfy tax withholding of the Reporting Person upon settlement of previously reported awards as required by the award agreement and exempt under Rule 16b-3. |
| Common StockSEC Table I · non-derivative | Direct | 110,864 |
Reported balance
After 2023-03-13 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-03-13 · Gift · Disposed 39,027 · Balance 110,864 F2: Total includes previously reported restricted stock units. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 191,622 |
Reported balance
After 2023-03-13 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2023-03-13 · Gift · Acquired 39,027 · Balance 191,622 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 181,622 |
Reported balance
After 2023-03-13 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2023-03-13 · Gift · Disposed 10,000 · Balance 181,622 F3: Bona fide gift to a charitable foundation. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan ESOP | 926.64 |
Reported balance
Holding disclosure · report date 2023-03-13 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 926.64 |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 389.79 |
Reported balance
Holding disclosure · report date 2023-03-13 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 389.79 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares used to satisfy tax withholding of the Reporting Person upon settlement of previously reported awards as required by the award agreement and exempt under Rule 16b-3.
F2: Total includes previously reported restricted stock units.
F3: Bona fide gift to a charitable foundation.
Kyndryl Holdings, Inc.
Report date July 30, 2026 · Filed August 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 97,930 |
Reported balance
After 2026-07-30 transaction · row 1
1 source rowRow 1 · 2026-07-30 · Grant · Acquired 17,844 · Balance 97,930 F1: Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2027 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2026 Annual Meeting of Stockholders). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2027 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2026 Annual Meeting of Stockholders).
Phillips 66
Report date March 16, 2026 · Filed March 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 949 |
Reported balance
After 2026-03-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-16 · Grant · Acquired 949 · Balance 949 F1: Grant of Restricted Stock Units (RSUs) that convert to Phillips 66 common stock on a 1-for-1 basis. This is a prorated amount of the annual grant to reflect the new director joining the board. F2: The price reflected above is the average of the high and the low price of the Company's stock on March 16, 2026. F3: Includes 949 RSUs that settle for shares of Phillips 66 common stock on a 1-for-1 basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Restricted Stock Units (RSUs) that convert to Phillips 66 common stock on a 1-for-1 basis. This is a prorated amount of the annual grant to reflect the new director joining the board.
F2: The price reflected above is the average of the high and the low price of the Company's stock on March 16, 2026.
F3: Includes 949 RSUs that settle for shares of Phillips 66 common stock on a 1-for-1 basis.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DOW CHEMICAL CO /DE/
Report date August 31, 2017 · Filed September 05, 2017
Section 16 reporting ended · disclosed 2017-09-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 1
1 source rowRow 1 · 2017-08-31 · Disposition to issuer · Disposed 56,870 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F2: Includes 18,710 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 21,200 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 16,960 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment. |
| CommonSEC Table I · non-derivative | IndirectBy 401(k) Plan | 0 |
Reported balance
After 2017-08-31 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-08-31 · Disposition to issuer · Disposed 311.636 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. |
| CommonSEC Table I · non-derivative | IndirectBy 401(k) Plan ESOP | 0 |
Reported balance
After 2017-08-31 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2017-08-31 · Disposition to issuer · Disposed 2,767.1669 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. |
| CommonSEC Table I · non-derivative | IndirectBy Trust | 0 |
Reported balance
After 2017-08-31 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2017-08-31 · Disposition to issuer · Disposed 106,387.9183 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.00 · Expires 2022-02-10 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-08-31 · Disposition to issuer · Disposed 82,420 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.19 · Expires 2027-02-10 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-08-31 · Disposition to issuer · Disposed 86,220 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F5: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.38 · Expires 2021-02-11 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-08-31 · Disposition to issuer · Disposed 18,600 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.79 · Expires 2020-02-12 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-08-31 · Disposition to issuer · Disposed 22,400 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.01 · Expires 2026-02-12 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-08-31 · Disposition to issuer · Disposed 106,850 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.53 · Expires 2019-02-13 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-08-31 · Disposition to issuer · Disposed 11,288 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.44 · Expires 2025-02-13 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-08-31 · Disposition to issuer · Disposed 95,610 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F7: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.71 · Expires 2024-02-14 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2017-08-31 · Disposition to issuer · Disposed 96,220 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.62 · Expires 2018-02-15 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2017-08-31 · Disposition to issuer · Disposed 30,750 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.16 · Expires 2023-02-15 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2017-08-31 · Disposition to issuer · Disposed 210,880 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
F2: Includes 18,710 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 21,200 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 16,960 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment.
F3: This option was fully vested and exercisable at the time of the Merger.
F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option.
F5: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms.
F6: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019.
F7: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018.
DuPont de Nemours, Inc.
Report date April 01, 2019 · Filed April 04, 2019
Section 16 reporting ended · disclosed 2019-04-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 184,509 |
Reported balance
After 2019-04-01 transaction · row 1
1 source rowRow 1 · 2019-04-01 · Grant · Acquired 55,650 · Balance 184,509 F1: Performance share units not previously reportable vested upon determination by the DowDuPont Inc. Compensation Committee on April 1, 2019, determined that the synergy capture maximum performance criteria had been met. Additional performance-based targets remain. Performance share units will be settled in one installment on or about September 1, 2019, subject to continued employment. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 444.639 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 444.639 |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan ESOP | 2,782.333 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,782.333 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 151,313.9183 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 151,313.9183 |
Filing footnotes · ownership attribution and instrument terms
F1: Performance share units not previously reportable vested upon determination by the DowDuPont Inc. Compensation Committee on April 1, 2019, determined that the synergy capture maximum performance criteria had been met. Additional performance-based targets remain. Performance share units will be settled in one installment on or about September 1, 2019, subject to continued employment.
Wolverine Bancorp, Inc.
Report date October 17, 2017 · Filed October 17, 2017
Section 16 reporting ended · disclosed 2017-10-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-10-17 transaction · row 1
1 source rowRow 1 · 2017-10-17 · Other · Disposed 2,507 · Balance 0 F1: Each share of common stock was converted into and became exchangeable for the right to receive 1.0152 shares of Horizon Bancorp common stock and $14.00 in cash. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse's IRA | 0 |
Reported balance
After 2017-10-17 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-10-17 · Other · Disposed 3,000 · Balance 0 F1: Each share of common stock was converted into and became exchangeable for the right to receive 1.0152 shares of Horizon Bancorp common stock and $14.00 in cash. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $26.75 · Expires 2026-09-12 | Direct | 0 |
Reported balance
After 2017-10-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-10-17 · Other · Disposed 7,500 · Balance 0 F2: Stock options have been cancelled and each option holder will receive a cash payment upon such cancellation in an amount equal to the product of (i) the number of shares of Issuer common stock provided for by such option and (ii) $40.00 minus the exercise price of the option. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $17.30 · Expires 2022-08-21 | Direct | 0 |
Reported balance
After 2017-10-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-10-17 · Other · Disposed 7,522 · Balance 0 F2: Stock options have been cancelled and each option holder will receive a cash payment upon such cancellation in an amount equal to the product of (i) the number of shares of Issuer common stock provided for by such option and (ii) $40.00 minus the exercise price of the option. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of common stock was converted into and became exchangeable for the right to receive 1.0152 shares of Horizon Bancorp common stock and $14.00 in cash.
F2: Stock options have been cancelled and each option holder will receive a cash payment upon such cancellation in an amount equal to the product of (i) the number of shares of Issuer common stock provided for by such option and (ii) $40.00 minus the exercise price of the option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2018 Filed Feb 22, 2018 22:18 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Disposition to issuerCommon Stock | 50,183 | $71.62 | $3,594,106.46 |
DisclosureSEC source: 0001225208-18-003809 · doc4.xml · nonDerivative · entry 1 Ungerleider Howard I · CIK 0001514396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,752 F1 · kind: The deferred shares of Common stock converted from performance based awards to be delivered on or about February 13, 2018, were settled in cash on February 20, 2018 at the election of the Reporting Person. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 00:41 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 268,435 | $0.00 Strike: $71.85 | $0.00 |
DisclosureSEC source: 0001225208-18-003481 · doc4.xml · derivative · entry 5 Ungerleider Howard I · CIK 0001514396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,435 Underlying: Common Stock · 268,435 shares Expires 2028-02-15 F3 · security: Granted under The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F4 · derivative.exercise_date: This option will vest in three equal installments beginning on February 15, 2019. Option shares may be used to satisfy withholding taxes. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:14 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 30,750 | $0.00 Strike: $38.62 | $0.00 |
DisclosureSEC source: 0001225208-18-003047 · doc4.xml · derivative · entry 8 Ungerleider Howard I · CIK 0001514396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,750 shares Expires 2018-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F4 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2009. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:14 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | OtherCommon Stock | 9,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003047 · doc4.xml · nonDerivative · entry 5 Ungerleider Howard I · CIK 0001514396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 114,302.9183 F2 · kind: Change in nature of ownership. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:14 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Tax withholdingCommon Stock | 16,701 | $71.11 | $1,187,608.11 |
DisclosureSEC source: 0001225208-18-003047 · doc4.xml · nonDerivative · entry 4 Ungerleider Howard I · CIK 0001514396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,646 Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:14 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | OtherCommon Stock | 9,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003047 · doc4.xml · nonDerivative · entry 3 Ungerleider Howard I · CIK 0001514396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,347 F2 · kind: Change in nature of ownership. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:14 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Tax withholdingCommon Stock | 4,134 | $71.11 | $293,968.74 |
DisclosureSEC source: 0001225208-18-003047 · doc4.xml · nonDerivative · entry 2 Ungerleider Howard I · CIK 0001514396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,262 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:14 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionCommon Stock | 30,750 | $38.62 | $1,187,565.00 |
DisclosureSEC source: 0001225208-18-003047 · doc4.xml · nonDerivative · entry 1 Ungerleider Howard I · CIK 0001514396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 21, 2018 00:41 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Tax withholdingCommon Stock | 6,156 | $70.75 | $435,537.00 |
DisclosureSEC source: 0001225208-18-003481 · doc4.xml · nonDerivative · entry 1 Ungerleider Howard I · CIK 0001514396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,489 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. F2 · shares: Shares used to satisfy withholding taxes on delivery of deferred stock granted February 13, 2015 as previously reported. Read SEC document |
| December 12, 2017 Filed Dec 15, 2017 11:07 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018709 · doc4.xml · nonDerivative · entry 1 Ungerleider Howard I · CIK 0001514396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 104,387.9183 Read SEC document |
| October 17, 2017 Filed Oct 17, 2017 15:14 UTC | Wolverine Bancorp, Inc. WBKC · Entity 172427 | OtherStock Options · Derivative | 7,522 | Not disclosed Strike: $17.30 | Not disclosed |
DisclosureSEC source: 0001140361-17-038849 · doc1.xml · derivative · entry 4 Ungerleider Howard I · CIK 0001514396 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,522 shares Expires 2022-08-21 F2 · price: Stock options have been cancelled and each option holder will receive a cash payment upon such cancellation in an amount equal to the product of (i) the number of shares of Issuer common stock provided for by such option and (ii) $40.00 minus the exercise price of the option. Read SEC document |
| October 17, 2017 Filed Oct 17, 2017 15:14 UTC | Wolverine Bancorp, Inc. WBKC · Entity 172427 | OtherStock Options · Derivative | 7,500 | Not disclosed Strike: $26.75 | Not disclosed |
DisclosureSEC source: 0001140361-17-038849 · doc1.xml · derivative · entry 3 Ungerleider Howard I · CIK 0001514396 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2026-09-12 F2 · price: Stock options have been cancelled and each option holder will receive a cash payment upon such cancellation in an amount equal to the product of (i) the number of shares of Issuer common stock provided for by such option and (ii) $40.00 minus the exercise price of the option. F2 · balance_after: Stock options have been cancelled and each option holder will receive a cash payment upon such cancellation in an amount equal to the product of (i) the number of shares of Issuer common stock provided for by such option and (ii) $40.00 minus the exercise price of the option. Read SEC document |
| October 17, 2017 Filed Oct 17, 2017 15:14 UTC | Wolverine Bancorp, Inc. WBKC · Entity 172427 | OtherCommon Stock | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-038849 · doc1.xml · nonDerivative · entry 2 Ungerleider Howard I · CIK 0001514396 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse's IRA Disclosed balance after: 0 F1 · price: Each share of common stock was converted into and became exchangeable for the right to receive 1.0152 shares of Horizon Bancorp common stock and $14.00 in cash. Read SEC document |
| October 17, 2017 Filed Oct 17, 2017 15:14 UTC | Wolverine Bancorp, Inc. WBKC · Entity 172427 | OtherCommon Stock | 2,507 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-038849 · doc1.xml · nonDerivative · entry 1 Ungerleider Howard I · CIK 0001514396 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Each share of common stock was converted into and became exchangeable for the right to receive 1.0152 shares of Horizon Bancorp common stock and $14.00 in cash. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 210,880 | Not disclosed Strike: $32.16 | Not disclosed |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · derivative · entry 14 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 210,880 shares Expires 2023-02-15 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 30,750 | Not disclosed Strike: $38.62 | Not disclosed |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · derivative · entry 13 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 30,750 shares Expires 2018-02-15 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 96,220 | Not disclosed Strike: $46.71 | Not disclosed |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · derivative · entry 12 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 96,220 shares Expires 2024-02-14 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 95,610 | Not disclosed Strike: $49.44 | Not disclosed |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · derivative · entry 11 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 95,610 shares Expires 2025-02-13 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F7 · derivative.exercise_date: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 11,288 | Not disclosed Strike: $9.53 | Not disclosed |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · derivative · entry 10 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 11,288 shares Expires 2019-02-13 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 106,850 | Not disclosed Strike: $46.01 | Not disclosed |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · derivative · entry 9 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 106,850 shares Expires 2026-02-12 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6 · derivative.exercise_date: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 22,400 | Not disclosed Strike: $27.79 | Not disclosed |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · derivative · entry 8 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 22,400 shares Expires 2020-02-12 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 18,600 | Not disclosed Strike: $38.38 | Not disclosed |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · derivative · entry 7 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 18,600 shares Expires 2021-02-11 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 86,220 | Not disclosed Strike: $61.19 | Not disclosed |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · derivative · entry 6 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 86,220 shares Expires 2027-02-10 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F5 · derivative.exercise_date: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 82,420 | Not disclosed Strike: $34.00 | Not disclosed |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · derivative · entry 5 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 82,420 shares Expires 2022-02-10 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerCommon | 106,387.9183 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · nonDerivative · entry 4 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerCommon | 2,767.1669 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · nonDerivative · entry 3 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan ESOP Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerCommon | 311.636 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · nonDerivative · entry 2 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:08 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerCommon | 56,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014587 · doc4.xml · nonDerivative · entry 1 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F2 · shares: Includes 18,710 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 21,200 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 16,960 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment. F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 21:18 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 6,811 | $61.72 | $420,374.92 |
DisclosureSEC source: 0001225208-17-003577 · doc4.xml · nonDerivative · entry 1 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,256 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. F2 · shares: Stock withheld on the delivery date to cover taxes for deferred stock granted on February 14, 2014, as previously reported. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 21:14 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 86,220 | $0.00 Strike: $61.19 | $0.00 |
DisclosureSEC source: 0001225208-17-003212 · doc4.xml · derivative · entry 5 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,220 Underlying: Common · 86,220 shares Expires 2027-02-10 F1 · security: Granted under The Dow Chemical Company 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 10, 2018. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 21:14 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | GrantCommon | 16,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003212 · doc4.xml · nonDerivative · entry 1 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,067 F1 · security: Granted under The Dow Chemical Company 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F2 · shares: Deferred shares to be delivered in one installment on or about February 10, 2020 contingent upon continuation of employment. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 20:38 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 23,510 | $0.00 Strike: $43.59 | $0.00 |
DisclosureSEC source: 0001225208-17-002233 · doc4.xml · derivative · entry 7 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 23,510 shares Expires 2017-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted under The Dow Chemical Company 1988 Award and Option Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning on February 16, 2008. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 20:38 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 16,977 | $60.37 | $1,024,816.61 |
DisclosureSEC source: 0001225208-17-002233 · doc4.xml · nonDerivative · entry 3 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,107 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 20:38 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 2,066 | $60.37 | $124,714.09 |
DisclosureSEC source: 0001225208-17-002233 · doc4.xml · nonDerivative · entry 2 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,084 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 20:38 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Exercise / conversionCommon | 23,510 | $43.59 | $1,024,800.90 |
DisclosureSEC source: 0001225208-17-002233 · doc4.xml · nonDerivative · entry 1 Ungerleider Howard I · CIK 0001514396 · Vice Chairman & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 15:24 UTC | Wolverine Bancorp, Inc. WBKC · Entity 172427 | GrantStock Options · Derivative | 7,500 | $0.00 Strike: $26.75 | $0.00 |
DisclosureSEC source: 0001140361-16-079784 · doc1.xml · derivative · entry 3 Ungerleider Howard I · CIK 0001514396 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-09-12 F3 · shares: Stock Options vest at a rate of 20% per year commencing on September 12, 2017. F3 · derivative.underlying_shares: Stock Options vest at a rate of 20% per year commencing on September 12, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.